Chris Britten

Chris Britten

Chairman at N4 PHARMA PLC

Net worth: - $ as of 2024-03-30

Health Technology
Commercial Services
Finance

Profile

Chris Britten is currently the Non-executive Chairman at N4 Pharma Plc since 2019.
He also holds the position of Senior Vice President-Merges & Acquisitions at Advanz Pharma Corp.
Ltd., Head-Mergers & Acquisitions at Neuraxpharm UK Ltd., and Operations Manager at Avenue Machinery Corp.
In the past, Dr. Britten served as a Non-Executive Director at Phico Therapeutics Ltd., Director-Life Sciences at Deloitte LLP (United Kingdom), Managing Director at Torreya Partners (Europe) LLP, Global Head-Mergers & Acquisitions at Sandoz AG, and Head-Business Development at Sanofi Pasteur MSD SNC.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2022-12-30 0 ( -.--% ) - $ 2024-03-30

Chris Britten active positions

CompaniesPositionStart
N4 PHARMA PLC Chairman 2023-07-31
ADVANZ PHARMA CORP. LIMITED Corporate Officer/Principal -
Neuraxpharm UK Ltd. Corporate Officer/Principal -
Chief Operating Officer -
All active positions of Chris Britten

Former positions of Chris Britten

CompaniesPositionEnd
Corporate Officer/Principal -
Corporate Officer/Principal -
Corporate Officer/Principal -
Corporate Officer/Principal -
Director/Board Member -
See the detail of Chris Britten's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Chris Britten's experience

Connections

18

1st degree connections

9

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies1
N4 PHARMA PLC

Health Technology

Private companies8

Health Technology

Commercial Services

Commercial Services

Health Technology

Health Technology

Finance

Neuraxpharm UK Ltd.

Distribution Services

See company connections